Year 2021 (55)

Edition nr. 6


New authorisation policy for diabetes drugs

Summary The oral blood glucose-lowering drug rosiglitazone has had a turbulent history. After its authorisation, it was found that the risk of myocardial infarction was larger with rosiglitazone than with other oral blood glucose lowering drugs. ...

In short Read article


Drugs for COVID-19: tocilizumab

Published studies into the effects of tocilizumab in the treatment of patients with COVID-19 differ greatly in the way they have been designed and conducted. Comparisons are hampered by differences in aspects like the severity of the COVID pneumo ...

In short Read article